Adma Biologics

Adma Biologics

ADMA· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +6.4% in FY2025

Adam S. Grossman is the CEO of Adma Biologics and was paid $10.2M in FY2025 (Dec), up 29%.

Pay$100 in the stock at the end of FY21 → $1.3K
CEO pay is from each Adma Biologics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Adam S. GrossmanFY2025
  2. 2Kaitlin KestenbergFY2025
  3. 3Brad L. TadeFY2025
  4. 4Paul Terence Kohler, Jr.FY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Adma Biologics paid its 4 named executives $18.8M in total in FY2025 (Dec). CEO Adam S. Grossman was paid $10.2M of that.

Name
Adam S. GrossmanPresident, Chief Executive Officer and Director
Kaitlin KestenbergChief Operating Officer & Senior Vice President, Compliance
Brad L. TadeFormer Executive Vice President and Chief Financial Officer
Paul Terence Kohler, Jr.Current Chief Financial Officer and Treasurer

of each named executive, from the Summary Compensation Table of each proxy.

Peers21

See all

The FY2025 (Dec) proxy of Adma Biologics names 21 peer companies for pay. Among Adma Biologics and these peers, CEO pay was 3rd highest of 4 and total shareholder return was the lowest of 4.

3rd highest of 4in Adma Biologics and its pay peers, FY2025 (Dec) by CEO pay:

$7.9M$33.2M

4th highest of 4in Adma Biologics and its pay peers, FY2025 (Dec) by total shareholder return:

$106$217

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board2

See all
  • Steven A. ElmsChair · 18 yr on the boardIndependentGovernance and Nominations—Paid as an executive
  • Young T. KwonDirector · 4 yr on the boardIndependentAudit (Chair), Compensation (Chair)—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 15, 2026FY2025
Annual report10-KFeb 25, 2026FY2025
Proxy statementDEF 14AApr 15, 2025FY2024
Annual report10-KMar 18, 2025FY2024
Proxy statementDEF 14AApr 15, 2024FY2023
Annual report10-KFeb 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data